Fmoc-N-Me-Thr(tBu)-OH

Fmoc-N-Me-Thr(tBu)-OH is an Fmoc-protected, N-methylated threonine derivative bearing a tert-butyl-protected side-chain hydroxyl, combining a chiral amino acid core with orthogonally protected functional groups. The molecule contains an Fmoc carbamate on the nitrogen for compatibility with iterative solid-phase peptide synthesis, alongside a stereogenic center at the threonine alpha position and a side-chain oxygen masked as a tBu ether. N-methylation changes amide hydrogen-bonding capacity and can influence backbone conformational preferences in peptide and peptidomimetic contexts, while the protected alcohol supports controlled deprotection chemistry. The resulting reactivity profile favors peptide coupling at the activated carboxyl group while deferring side-chain functionalization until selective removal of the tBu and/or Fmoc groups.

1. Peptide Synthesis

Fmoc-N-Me-Thr(tBu)-OH is used as a protected amino acid building block for peptide coupling workflows where Fmoc deprotection and subsequent amide bond formation are required. The Fmoc carbamate enables stepwise N-terminal activation under base-labile conditions, while the carboxylic acid can be converted to standard activated coupling species to install the residue at a growing peptide chain. The N-methyl substituent supports incorporation of methylated amide motifs that are common in helix-stabilized sequences and constrained peptidomimetics, whereas the tBu-protected threonine hydroxyl prevents side reactions during chain assembly. Downstream deprotection allows controlled exposure of the threonine side-chain oxygen for further derivatization, enabling synthesis of phosphorylation-mimic analogs, ester-linked motifs, and other oxygen-functionalized peptide variants.

2. Peptidomimetics And SAR Studies

Fmoc-N-Me-Thr(tBu)-OH supports structure-activity relationship studies in medicinal chemistry through incorporation of N-methylated threonine units that modulate polarity, hydrogen bonding, and local conformational behavior. The protected side-chain hydroxyl allows synthesis of analog libraries where the oxygen can later be converted into ethers, esters, or other functional handles without perturbing earlier coupling steps. The defined stereochemistry at the threonine center helps maintain consistent spatial presentation of the side-chain substituent across analog series, supporting reliable comparisons in SAR-focused fragment and scaffold optimization. The Fmoc/tBu orthogonal protection pattern also enables sequential functional group unveiling, which can be applied to generate targeted analogs for binding studies and mechanistic probing of peptide-like chemotypes.

3. Side-Chain Functionalization

Fmoc-N-Me-Thr(tBu)-OH serves as a controlled precursor for side-chain oxygen chemistry where selective unmasking of the threonine hydroxyl is needed after peptide or scaffold construction. The tBu-protected alcohol remains inert during Fmoc-based assembly, reducing undesired formation of mixed esters or competing nucleophilic reactions during coupling and purification. Following deprotection, the exposed hydroxyl can be functionalized to produce O-alkylated or O-acylated derivatives, including handles for conjugation, tagging, or incorporation into larger molecular architectures. The N-methylated backbone further provides a stable amide pattern that can be carried through subsequent derivatization steps, supporting generation of oxygen-functional peptide analogs and amino acid-derived intermediates for downstream chemical biology research.

4. Chemical Biology And Bioconjugation

Fmoc-N-Me-Thr(tBu)-OH can be incorporated into chemically defined peptides used for chemical biology experiments where controlled conjugation sites are required. The protected threonine side-chain oxygen provides a latent functional group that can be revealed and converted into conjugatable moieties after assembly, enabling attachment of linkers, affinity tags, or reactive groups for biomolecule labeling strategies. The N-methyl amide pattern can improve metabolic stability characteristics of peptide-like constructs by reducing the number of backbone hydrogen bond donors, which can be relevant for maintaining structural integrity during labeling workflows. The Fmoc strategy supports reproducible synthesis of conjugation-ready sequences with consistent stereochemical presentation, facilitating the preparation of molecular probes for studying recognition, trafficking, or protein-interaction interfaces.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-N-Me-Thr(tBu)-OH is applicable to pharmaceutical intermediate preparation where protected amino acid derivatives are manufactured and used in controlled peptide synthesis routes. The orthogonal protection scheme, featuring Fmoc for base-labile N-terminal handling and tBu for acid-labile side-chain masking, aligns with common manufacturing practices that require predictable deprotection sequences and minimized side reactions. N-methylation provides a specific amide motif that can be incorporated into peptide intermediates for producing methylated peptide fragments or peptidomimetic building blocks used in process-scale synthesis. The compound's defined stereochemistry and protected functional groups support consistent downstream conversion into peptide fragments, enabling reliable feedstock preparation for fine chemical production and industrial peptide manufacturing operations.

6. Analytical Research Standards

Fmoc-N-Me-Thr(tBu)-OH can be used to prepare analytical standards and reference materials for method development in amino acid and peptide analysis. The combination of Fmoc and tBu protection provides a distinguishable protected form that can serve as a chromatographic or mass spectrometric marker for monitoring deprotection, coupling completeness, or impurity profiles during peptide synthesis. The N-methylated threonine structure contributes characteristic fragmentation behavior and retention trends that can aid in identifying N-methyl amide-containing residues in complex peptide mixtures. The stereochemically defined amino acid core further supports reproducible standard preparation for validating analytical workflows related to protected amino acid chemistry, peptide coupling chemistry, and peptide intermediate characterization.

1. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

3. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis